Malignant Peritoneal Neoplasm Recruiting Phase 3 Trials for Bupivacaine (DB00297)

Also known as: Peritoneal Cancer / Malignant neoplasm of peritoneum, unspecified / Malignant peritoneal neoplasm NOS

DBCOND0073968 (Malignant Peritoneal Neoplasm)Recruiting3 IdentifierTitlePurposeDrugs
NCT03359811Four Quadrants Transverse Abdominus Plane (4Q-TAP) Block With Plain and Liposomal Bupivacaine vs. Thoracic Epidermal Analgesia (TEA) in Patients Undergoing Cytoreductive Surgery With Hyperthermic Intraperitoneal Chemotherapy (CRS-HIPEC) on an Enhanced Recovery PathwayTreatment